ACTRN12618001394235招募中未知
A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement therapy in Lung Transplantation
The Alfred Hospital0 个研究点目标入组 40 人开始时间: 2018年8月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Male and female aged greater than or equal to 18 years
- •Undergoing single lung transplant, bilateral sequential lung transplant (BSLT) or heart-lung transplant (HLT)
- •Able to give written informed consent
- •Able to understand and comply with all trial requirements
排除标准
- •Known allergy to IVIg
- •Active treatment for acute cellular or antibody mediated rejection
- •Known history of severe selective IgA deficiency (<5mg/dL)
- •Patients who have received IVIg pre- or post –transplant for any medical indication
- •History of non-provoked thrombotic events in preceding 3 months
- •LTx recipients who are not followed up long-term at Alfred Health
- •Re-transplant
- •Hospitalisation requiring intubation or mechanical ventilation at the time of enrolment.
- •Any other severe condition which in the investigator’s judgment may interfere with the trial evaluations or severely compromise patient safety
- •Currently involved in another investigational interventional trial
研究者
相似试验
尚未招募
3 期
Evaluating The desired effect Of the drug Imeglimin In Patients With Polycystic Ovarian SyndromeCTRI/2024/06/068921Riya Sharma self
已完成
不适用
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with obsessive-compulsive disorder (OCD)Mental and Behavioural DisordersObsessive-compulsive disorderISRCTN70977225Institute of Psychiatry, Kings College London (UK)24
进行中（未招募）
1 期
A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorderEUCTR2008-006947-38-GBKing's College London (Institute of Pyschiatry)24
进行中（未招募）
1 期
Trial of oxytocin for the treatment of emotional withdrawal symptoms and for relapse prevention in abstinent heroin dependent individualsOpioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individuals experience following detoxification.MedDRA version: 20.0 Level: LLT Classification code 10057379 Term: Addiction relapse System Organ Class: 100000004873MedDRA version: 20.0 Level: LLT Classification code 10001126 Term: Addiction any drug System Organ Class: 100000004873EUCTR2014-002708-26-GBniversity of Surrey3
尚未招募
3 期
The Myer Foundation Study into Multiple SclerosisRelapsing remitting multiple sclerosisNeurological - Multiple sclerosisACTRN12606000359538Melbourne Health20